SCHEMBL3794850

SCHEMBL3794850

O=C(Nc1ccccc1Cl)c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.74
▸ RAB9A P51151 4/20 0.74
▸ L3MBTL1 Q9Y468 2/20 0.70
▸ ALDH1A1 P00352 2/20 0.70
▸ GLA P06280 1/20 0.70
▸ ATM Q13315 1/20 0.70
▸ APOBEC3A P31941 1/20 0.68
▸ CTDSP1 Q9GZU7 1/20 0.68
▸ APOBEC3G Q9HC16 1/20 0.68
▸ HPGD P15428 3/20 0.67
▸ CYP1A2 P05177 2/20 0.67
▸ CYP2C19 P33261 1/20 0.67
▸ MAPT P10636 3/20 0.63
▸ HDAC1 Q13547 2/20 0.63
▸ HDAC8 Q9BY41 1/20 0.63
▸ HDAC6 Q9UBN7 1/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ LMNA P02545 1/20 0.63
▸ KMT2A Q03164 1/20 0.63
▸ SMN1; SMN2 Q16637 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29960964 1.00 NPC1 (0.74) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL13726997 0.91 CYP1A2 (0.72) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL16583878 0.91 NPC1 (0.73) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL14252928 0.89 MEN1 (0.79) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL29083336 0.87 NPC1 (0.62) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL28577755 0.87 NPC1 (0.73) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL9621459 0.87 MEN1 (0.82) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL3785470 0.85 LMNA (0.66) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL25229349 0.85 NPC1 (0.71) NPC1RAB9AL3MBTL1ALDH1A1GLA
SCHEMBL9902869 0.85 GAA (0.71) NPC1RAB9AL3MBTL1ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9656927-B2 Process for the synthesis of carboxylic acid derivatives COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-05-23 — — US claimed
US-20160272554-A1 PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-09-22 — — US claimed
WO-2015063798-A1 A PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-05-07 — — WO claimed
CN-1155278-A Arylthio compounds as antibacteral and antiviral agents WARNER LAMBERT CO (US) 1997-07-23 — — CN claimed
CN-115057794-B Method for removing methylation of cerium catalytic oxidation amide by visible light induction 桂林理工大学 2023-11-17 — — CN disclosed
CN-114369038-B Method for synthesizing amide compound by photocatalysis 苏州大学张家港工业技术研究院 2023-06-23 — — CN disclosed
CN-115057794-A Novel method for removing methylation of cerium-induced catalytic oxidation amide by visible light 桂林理工大学 2022-09-16 — — CN disclosed
CN-114369038-A Method for synthesizing amide compound through photocatalysis 苏州大学张家港工业技术研究院 2022-04-19 — — CN disclosed
CN-111471023-A Method for synthesizing quinazolinone compound under photocatalysis condition 河南大学 2020-07-31 — — CN disclosed
CN-108727428-B β -aminophosphonic acid derivatives and process for their preparation 苏州大学 2020-05-08 — — CN disclosed
CN-110218158-A A method of photocatalytic synthesis is at amide compound in water phase 福建医科大学 2019-09-10 — — CN disclosed
CN-109456214-A A method of the benzamide compound under microwave condition in water phase 福建医科大学 2019-03-12 — — CN disclosed
CN-100335468-C Diaryl amidine compound, its production, medicinal composition and use DRUG INST CHINESE ACADEMY OF M (CN) 2007-09-05 — — CN disclosed
CN-1712398-A Diaryl amidine compound, its production, medicinal composition and use DRUG INST CHINESE ACADEMY OF M (CN) 2005-12-28 — — CN disclosed
CN-1155278-A Arylthio compounds as antibacteral and antiviral agents WARNER LAMBERT CO (US) 1997-07-23 — — CN disclosed
US-5514740-A SHEET OR FILM HAVING CUPRIC SULFIDE DISPERSED THEREIN DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1996-05-07 — — US disclosed
US-4175191-A 4-Phenyl isoquinolines SANDOZ, INC. (US) 1979-11-20 — — US disclosed
US-4093648-A ANTIANAPHYLACTIC AGENTS RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 1978-06-06 — — US disclosed
US-3989704-A 3-Substituted-4-aryl isoquinolines SANDOZ, INC. (US) 1976-11-02 — — US disclosed
US-3944570-A ANTIINFLAMMATORY SANDOZ, INC. (US) 1976-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272554-A1 PROCESS FOR THE SYNTHESIS OF CARBOXYLIC ACID DERIVATIVES PCCA, CPS1, CS NPC1 929/4885RAB9A 3096/4885L3MBTL1 4528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback